Tongji Hospital

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

218

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

31 drugs in development

Approved1

Phase 33

Phase 25

Phase 110

Preclinical16

By Therapeutic Area

top 6

Oncology

922%

Nephrology

37%

Immunology

37%

Hematology

25%

Neurology

25%

Psychiatry

12%

R&D Momentum

86/100

Pipeline Velocity

66/100

Trial Completion Rate

94/100

Pipeline Concentration

20/100

Pipeline Freshness

65/100

Strategic Signals

↗Active in Psychiatry but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 5, 2026

Completed

Application of Peer Video Feedback Combied With Teacher Evaluation on Cardiopulmonary Resuscitation in Nursing Interns: a Randomized Controlled Trial

Nov 4, 2026

Recruiting

Effects of Fospropofol Disodium-Based Total Intravenous Anesthesia and Intravenous-Inhalation Combined Anesthesia on Surgical Field Quality in Adult Endoscopic Sinus Surgery: A Randomized Controlled Study

Nov 4, 2026

Recruiting

Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage

Earlier

Oct 22, 2026TrialReal-World Study of Photodynamic Therapy for Cervical Intraepithelial Neoplasia Grade 2

Oct 15, 2026TrialA Single-Arm, Multicenter, Exploratory Study of Lenvatinib Combined With PD-1 Inhibitor in Advanced Solid Tumors With Chromosome 11q13 Amplification

Oct 15, 2026TrialRandomized, Double-blind, Placebo-controlled, Multi-center Study on the Treatment of Tension-type Headache With Zhixuan Analgesic Tablets

Oct 9, 2026TrialA Prospective, Multicenter, Open-Label Phase II Study of Response-Guided Bladder Preservation With Trastuzumab Rezetecan Plus Adebrelimab and Concurrent Bladder Radiotherapy in Patients With HER2-Expressing Muscle-Invasive Bladder Cancer

Oct 9, 2026TrialNon-invasive Differentiation of Uterine Sarcomas From Uterine Fibroids Using Multiparametric MRI Radiomics

2 more events

Oct 9, 2026TrialA Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma

Oct 7, 2026TrialNew Combination of ETV, TQ-A3334 and TQ-B2450 for the Treatment of Chronic Hepatitis B Virus Infection

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(1 drug)

—

Cardiovascular(1 drug)

Hematology(2 drugs)

—

Hematology(2 drugs)

Immunology(3 drugs)

—

Immunology(3 drugs)

Infectious Disease(1 drug)

—

Infectious Disease(1 drug)

Musculoskeletal(1 drug)

—

Musculoskeletal(1 drug)

Nephrology(3 drugs)

—

Nephrology(3 drugs)

Neurology(2 drugs)

—

Neurology(2 drugs)

Oncology(9 drugs)

—

Oncology(9 drugs)

Ophthalmology(1 drug)

—

Ophthalmology(1 drug)

Psychiatry(1 drug)

—

Psychiatry(1 drug)

Rare Disease(1 drug)

—

Rare Disease(1 drug)

Respiratory(1 drug)

—

Respiratory(1 drug)

Unknown / Other(15 drugs)

—

Unknown / Other(15 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)